Literature DB >> 25303669

Prevalence of and factors associated with increased arterial stiffness in patients with primary Sjögren's syndrome.

José Mario Sabio1, Isabel Sánchez-Berná, Josefina Martinez-Bordonado, José Antonio Vargas-Hitos, Nuria Navarrete-Navarrete, Manuela Expósito Ruíz, Juan Jiménez-Alonso.   

Abstract

OBJECTIVE: To compare the presence of subclinical atherosclerosis measured by means of pulse wave velocity (PWV) in women with primary Sjögren's syndrome (SS) versus a healthy age- and sex-matched control group, and to identify factors independently associated with PWV in primary SS.
METHODS: Forty-four women with primary SS and 78 age-matched healthy women without overt cardiovascular (CV) diseases were assessed for traditional and nontraditional CV risk factors. PWV was also performed. A linear regression analysis was used to identify factors independently associated with PWV in primary SS.
RESULTS: Women with primary SS had significantly higher PWV than controls (P = 0.030), and the frequency of increased PWV was significantly higher in this group (25% versus 8%; P = 0.013). The proportion of patients ages ≤50 years (ratio 4.6) with increased PWV was almost 2-fold higher than those ages >50 years (ratio 2.4) with respect to controls. Positivity for anti-SSB was more frequent in patients with normal PWV than in those with increased PWV (61% versus 18%; P = 0.034). Women with primary SS and increased PWV had lower levels of 25-hydroxyvitamin D (25[OH]D; P = 0.047) than primary SS patients with normal PWV. In addition, 25(OH)D levels tended to correlate inversely with PWV in women with primary SS (P = 0.067), but not in controls (P = 0.97). In multivariate analysis, the Framingham Risk Score (FRS) and Sjögren's Syndrome Damage Index emerged as factors independently correlated with PWV.
CONCLUSION: Women with primary SS had higher PWV than controls, but a similar FRS. The FRS and chronic damage were found to be independently associated with PWV.
Copyright © 2015 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2015        PMID: 25303669     DOI: 10.1002/acr.22493

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  8 in total

1.  Metabolic syndrome in Sjögren's syndrome patients: a relevant concern for clinical monitoring.

Authors:  Kristopherson Lustosa Augusto; Eloisa Bonfa; Rosa Maria Rodrigues Pereira; Cleonice Bueno; Elaine Pires Leon; Vilma Santos Trindade Viana; Sandra Gofinet Pasoto
Journal:  Clin Rheumatol       Date:  2015-09-14       Impact factor: 2.980

Review 2.  Cardiovascular Disease in Primary Sjögren's Syndrome: Raising Clinicians' Awareness.

Authors:  Mihnea Casian; Ciprian Jurcut; Alina Dima; Ancuta Mihai; Silviu Stanciu; Ruxandra Jurcut
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

Review 3.  Cardiovascular Involvement in Sjögren's Syndrome.

Authors:  Fabiola Atzeni; Francesco Gozza; Giacomo Cafaro; Carlo Perricone; Elena Bartoloni
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

4.  Evaluation of subclinical atherosclerosis by ultrasound radiofrequency data technology in patients with primary Sjögren's syndrome.

Authors:  Cem Ozisler; Hatice Kaplanoglu
Journal:  Clin Rheumatol       Date:  2018-10-17       Impact factor: 2.980

Review 5.  Subclinical Atherosclerosis in Primary Sjögren's Syndrome: Does Inflammation Matter?

Authors:  Elena Bartoloni; Alessia Alunno; Giacomo Cafaro; Valentina Valentini; Onelia Bistoni; Angelo Francesco Bonifacio; Roberto Gerli
Journal:  Front Immunol       Date:  2019-04-17       Impact factor: 7.561

6.  Lipoprotein-associated phospholipase A2 and carotid intima-media thickness in primary Sjögren syndrome.

Authors:  Selcan Gültuna; Sevinç Can Sandıkçı; Hatice Kaplanoğlu; Fevzi Nuri Aydın; Funda Seher Özalp Ateş
Journal:  Arch Rheumatol       Date:  2021-10-16       Impact factor: 1.007

7.  Increased risk of coronary heart disease among patients with primary Sjögren's syndrome: a nationwide population-based cohort study.

Authors:  Xue-Fen Wu; Jing-Yang Huang; Jeng-Yuan Chiou; Huang-Hsi Chen; James Cheng-Chung Wei; Ling-Li Dong
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

8.  Adropin Serum Levels in Patients with Primary Sjögren's Syndrome.

Authors:  Marijana Janković Danolić; Dijana Perković; Marin Petrić; Igor Barišić; Katarina Gugo; Joško Božić
Journal:  Biomolecules       Date:  2021-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.